These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1167 related articles for article (PubMed ID: 3229319)

  • 1. A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
    Atassi G; Dumont P; Kabbe HJ; Yoder O
    Drugs Exp Clin Res; 1988; 14(9):571-4. PubMed ID: 3229319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.
    Plowman J; Narayanan VL; Dykes D; Szarvasi E; Briet P; Yoder OC; Paull KD
    Cancer Treat Rep; 1986 May; 70(5):631-5. PubMed ID: 3708611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical antitumor activity of batracylin (NSC 320846).
    Plowman J; Paull KD; Atassi G; Harrison SD; Dykes DJ; Kabbe HJ; Narayanan VL; Yoder OC
    Invest New Drugs; 1988 Sep; 6(3):147-53. PubMed ID: 3192381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
    Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
    Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental antitumor activity and toxicity of the selected triazolo- and imidazoacridinones.
    Kuśnierczyk H; Chołody WM; Paradziej-Lukowicz J; Radzikowski C; Konopa J
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):415-23. PubMed ID: 8572901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
    McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
    Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of batracylin (NSC-320846) against solid tumors of mice.
    Mucci-LoRusso P; Polin L; Bissery MC; Valeriote F; Plowman J; Luk GD; Corbett TH
    Invest New Drugs; 1989 Nov; 7(4):295-306. PubMed ID: 2557298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
    Finch RA; Shyam K; Penketh PG; Sartorelli AC
    Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases.
    Kruczynski A; Etiévant C; Perrin D; Imbert T; Colpaert F; Hill BT
    Br J Cancer; 2000 Dec; 83(11):1516-24. PubMed ID: 11076662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides.
    Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E
    Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor effects of a new antitumor agent, zinostatin stimalamer (YM881)--effects on experimental tumors in vitro and in vivo].
    Numasaki Y; Takahashi K; Masuda E; Nohara C; Maeda H
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2289-94. PubMed ID: 1834021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R
    Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Models of preclinical studies of anthracyclines].
    Fizames C
    Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.
    LoRusso P; Wozniak AJ; Polin L; Capps D; Leopold WR; Werbel LM; Biernat L; Dan ME; Corbett TH
    Cancer Res; 1990 Aug; 50(16):4900-5. PubMed ID: 2165850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antitumor activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine in murine tumors.
    Furusawa S; Mian AM
    Cancer Treat Rep; 1987 May; 71(5):441-6. PubMed ID: 3567967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the activity of alpha/beta-triglycidylurazol (TGU; NSC-332488): a new antineoplastic compound.
    Atassi G; Dumont P; Vanhaelen C
    Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1187-91. PubMed ID: 6541138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Apr; 42(4):1462-7. PubMed ID: 7060020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF; Muggia FM; Johnson RK
    Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 59.